US Patent 7998973 Tivozanib and temsirolimus in combination
Patent 7998973 was granted and assigned to AVEO Pharmaceuticals on August, 2011 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7998973 Tivozanib and temsirolimus in combination
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
